223 related articles for article (PubMed ID: 12119025)
1. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.
Pryor DE; O'Brate A; Bilcer G; Díaz JF; Wang Y; Wang Y; Kabaki M; Jung MK; Andreu JM; Ghosh AK; Giannakakou P; Hamel E
Biochemistry; 2002 Jul; 41(29):9109-15. PubMed ID: 12119025
[TBL] [Abstract][Full Text] [Related]
2. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
Gapud EJ; Bai R; Ghosh AK; Hamel E
Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
[TBL] [Abstract][Full Text] [Related]
3. The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site.
Hamel E; Sackett DL; Vourloumis D; Nicolaou KC
Biochemistry; 1999 Apr; 38(17):5490-8. PubMed ID: 10220336
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly.
Hamel E; Day BW; Miller JH; Jung MK; Northcote PT; Ghosh AK; Curran DP; Cushman M; Nicolaou KC; Paterson I; Sorensen EJ
Mol Pharmacol; 2006 Nov; 70(5):1555-64. PubMed ID: 16887932
[TBL] [Abstract][Full Text] [Related]
5. Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.
Gaitanos TN; Buey RM; Díaz JF; Northcote PT; Teesdale-Spittle P; Andreu JM; Miller JH
Cancer Res; 2004 Aug; 64(15):5063-7. PubMed ID: 15289305
[TBL] [Abstract][Full Text] [Related]
6. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.
Kanakkanthara A; Northcote PT; Miller JH
Mol Cancer Ther; 2012 Feb; 11(2):393-404. PubMed ID: 22180309
[TBL] [Abstract][Full Text] [Related]
7. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
[TBL] [Abstract][Full Text] [Related]
8. Microtubule-stabilizing agents based on designed laulimalide analogues.
Mooberry SL; Randall-Hlubek DA; Leal RM; Hegde SG; Hubbard RD; Zhang L; Wender PA
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8803-8. PubMed ID: 15161976
[TBL] [Abstract][Full Text] [Related]
9. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent.
Liu J; Towle MJ; Cheng H; Saxton P; Reardon C; Wu J; Murphy EA; Kuznetsov G; Johannes CW; Tremblay MR; Zhao H; Pesant M; Fang FG; Vermeulen MW; Gallagher BM; Littlefield BA
Anticancer Res; 2007; 27(3B):1509-18. PubMed ID: 17595769
[TBL] [Abstract][Full Text] [Related]
11. Laulimalide and synthetic laulimalide analogues are synergistic with paclitaxel and 2-methoxyestradiol.
Clark EA; Hills PM; Davidson BS; Wender PA; Mooberry SL
Mol Pharm; 2006; 3(4):457-67. PubMed ID: 16889440
[TBL] [Abstract][Full Text] [Related]
12. βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.
Kanakkanthara A; Rowe MR; Field JJ; Northcote PT; Teesdale-Spittle PH; Miller JH
Cancer Lett; 2015 Sep; 365(2):251-60. PubMed ID: 26052091
[TBL] [Abstract][Full Text] [Related]
13. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
14. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis of the microtubule-stabilizing agent (-)-laulimalide.
Paterson I; De Savi C; Tudge M
Org Lett; 2001 Oct; 3(20):3149-52. PubMed ID: 11574017
[TBL] [Abstract][Full Text] [Related]
16. Synthetic approaches to the microtubule stabilizing agent (-)-laulimalide.
Crimmins MT
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):944-59. PubMed ID: 12478725
[TBL] [Abstract][Full Text] [Related]
17. Effect of 2'-OH acetylation on the bioactivity and conformation of 7-O-[N-(4'-fluoresceincarbonyl)-L-alanyl]taxol. A NMR-fluorescence microscopy study.
Jiménez-Barbero J; Souto AA; Abal M; Barasoain I; Evangelio JA; Acuña AU; Andreu JM; Amat-Guerri F
Bioorg Med Chem; 1998 Oct; 6(10):1857-63. PubMed ID: 9839015
[TBL] [Abstract][Full Text] [Related]
18. Non-taxoid site microtubule-stabilizing drugs work independently of tau overexpression in mouse N2a neuroblastoma cells.
Das V; Miller JH
Brain Res; 2012 Dec; 1489():121-32. PubMed ID: 23085090
[TBL] [Abstract][Full Text] [Related]
19. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization.
Jiménez-Barbero J; Amat-Guerri F; Snyder JP
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):91-122. PubMed ID: 12678753
[TBL] [Abstract][Full Text] [Related]
20. Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.
Kanakkanthara A; Wilmes A; O'Brate A; Escuin D; Chan A; Gjyrezi A; Crawford J; Rawson P; Kivell B; Northcote PT; Hamel E; Giannakakou P; Miller JH
Mol Cancer Ther; 2011 Aug; 10(8):1419-29. PubMed ID: 21653684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
